Friday, March 30, 2012: 3:40 PM-5:00 PM
Yerba Buena Salon 4-6 (San Francisco Marriott Marquis)
Speakers:Kelsey L. Hegarty, MBBS, FRACGP, PhD, University of Melbourne
Gene S. Feder, MD, FRCGP, University of Bristol
Angela Taft, MPH, PhD, La Trobe University
Harriet MacMillan, PhD, McMaster University
Learning Objectives:
- Discuss methodological involved in randomised controlled trials (RCT) of health care interventions for women survivors of intimate partner violence
- Discuss ethical issues involved in randomised controlled trials (RCT) of health care interventions for women survivors of intimate partner violence
- Recognize the challenges and benefits of conducting RCTs to test interventions aiming to improve outcomes for women survivors in health care settings
Description:
Presentations (30 mins) of methodological and ethical issues from 4 IPV trials will be followed by facilitated small group discussions (30 mins) of specific issues. The format will be interactive and guided by issues and questions raised by the presenters and by the participants. The facilitators will be flexible and be able to discuss issues of interest to the participants. In conclusion (20 mins), the group will summarise consensus points from each group for future RCTs on this topic.
See more of: Symposium